GE HealthCare Technologies Inc. Common Stock vs Hormel Foods Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Hormel Foods Corp trades at $20.05 (market cap $10.90B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2.8× Hormel Foods Corp's market cap, and Hormel Foods Corp pays the higher dividend (5.91%). Which is the better fit depends on your goals.
| GEHC | HRL | |
|---|---|---|
Market Cap | $30.93B | $10.90B |
Volume | 5,033,451 | 5,843,624 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $26.50 |
52-Week Low | $59.48 | $19.19 |
Enterprise Value | $39.39B | $12.89B |
Dividend Yield | 0.23% | 5.91% |
Typical Hold Time | — | 99 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Hormel Foods (HRL) trades at $19.21, down 0.47% with a bearish technical outlook. The stock shows mixed fundamentals with declining net margins (2.82% in 2026) but consistent earnings beats and a $1.06B Brakebush acquisition to expand foodservice presence. Valuation metrics include a P/E of 30.98 and P/S of 0.87, while analyst consensus is cautious with 20% buy ratings.
Investment outlook balances dividend stability (60-year growth streak) against margin pressures and acquisition integration risks. The consensus price target of $25 offers 30% upside, but weak technicals and shrinking dividend raises warrant caution. Key catalysts include Brakebush synergies and foodservice growth execution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →